For research use only. Not for therapeutic Use.
8-<wbr></wbr><em>iso</em> PGF<sub>2α</sub> is an isoprostane produced by the non-<wbr></wbr>enzymatic peroxidation of arachidonic acid in membrane phospholipids. It is present in human plasma in two distinct forms -<wbr></wbr> esterified in phospholipids and as the free acid. The ratio of these two forms is approximately 2:1, with a total plasma 8-<wbr></wbr><em>iso</em> PGF<sub>2α</sub> level of about 150 pg/ml in normal volunteers. In normal human urine, 8-<wbr></wbr><em>iso</em> PGF<sub>2α</sub> levels are about 180-<wbr></wbr>200 pg/mg of creatinine. 8-<wbr></wbr><em>iso</em> PGF<sub>2α</sub> is a weak TP receptor agonist in vascular smooth muscle. Conversely, 8-<wbr></wbr><em>iso</em> PGF<sub>2α</sub> inhibits platelet aggregation induced by U-<wbr></wbr>46619 (10
| Catalog Number | R052465 |
| CAS Number | 27415-26-5 |
| Synonyms | (5Z,8β,9α,11α,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic Acid;?7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-Heptenoic Acid; 15(S)-8-Iso-PGF2α; 15-F2t-IsoP; 15-F2t-Isoprostane; 8-Isoprostaglandin F2α; 8-epi-PGF2α; 8-iso-Prostaglandin |
| Molecular Formula | C20H34O5 |
| Purity | ≥95% |
| Target | Endogenous Metabolite |
| Storage | -20°C |
| IUPAC Name | (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid |
| InChI | InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16-,17+,18-,19+/m0/s1 |
| InChIKey | PXGPLTODNUVGFL-NAPLMKITSA-N |
| SMILES | CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O |
